Immunomedics Inc. (IMMU) News

News for Immunomedics Inc. (IMMU)

Sector News | Topic News

Wed, Feb 08, 2012

8:30 AM

Immunomedics Announces Second Quarter Fiscal 2012 Results and Clinical Program Developments - Globe Newswire

Tue, Jan 31, 2012

8:30 AM

Immunomedics Awarded Broad Patent for Anti-CD20 and Anti-CD22 Combination Therapy - Globe Newswire

Fri, Jan 20, 2012

12:07 PM

Immunomedics Reports Final Results From Phase Ib/II Study of Yttrium-90-Labeled Clivatuzumab Tetraxetan and Gemcitabine in Advanced Pancreatic Cancer - Globe Newswire

Wed, Jan 18, 2012

8:30 AM

Immunomedics Reports Clivatuzumab-Based Blood Test Highly Sensitive and Specific for Early-Stage Pancreatic Cancer Detection - Globe Newswire

Thu, Jan 12, 2012

8:30 AM

Immunomedics Announces Presentations at Gastrointestinal Cancers Symposium Showcasing Advances in Pancreatic Cancer Diagnosis and Therapy - Globe Newswire

Wed, Dec 28, 2011

1:00 AM

Immunomedics and UCB Announce Restructuring of Epratuzumab License Agreement - Globe Newswire

Wed, Dec 14, 2011

8:30 AM

Immunomedics Awarded New Patent for Improved Cell Lines for Protein Therapeutic Manufacturing - Globe Newswire

Tue, Dec 13, 2011

8:30 AM

Immunomedics Announces Results From Two Clinical Trials at Hematology Conference - Globe Newswire

Mon, Dec 12, 2011

8:00 PM

Immunomedics Develops Novel Antibody-Based Therapeutics for Mantle Cell and Other Lymphomas - Globe Newswire

3:18 PM

Immunomedics Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced High Rates of Response in Relapsed Immune Thrombocytopenia - Globe Newswire

Fri, Dec 09, 2011

8:30 AM

Immunomedics Creates Targeted Therapeutics for Solid Cancers - Globe Newswire

Wed, Dec 07, 2011

12:30 PM

Immunomedics Announces Outcome of 2011 Annual Meeting of Stockholders - Globe Newswire

Tue, Dec 06, 2011

8:37 AM

Immunomedics to Present at Oppenheimer 22nd Annual Healthcare Conference - Globe Newswire

Wed, Nov 16, 2011

9:35 AM

Immunomedics' Product Candidates to be Presented at the 2011 Annual Meeting of the American Society of Hematology - Globe Newswire

Tue, Nov 15, 2011

8:30 AM

Immunomedics Awarded Additional U.S. Patent for Anti-CD20 Treatment of Autoimmune Diseases - Globe Newswire

Fri, Nov 11, 2011

8:15 AM

Immunomedics Receives Thomas Alva Edison Patent Award From Research & Development Council of New Jersey - Globe Newswire

Tue, Nov 08, 2011

2:00 AM

Epratuzumab Phase IIB Data Demonstrated Sensitivity of BICLA, a Novel BILAG-Based Composite Endpoint - Globe Newswire

Mon, Nov 07, 2011

8:30 AM

Immunomedics to Participate in Upcoming Conferences - Globe Newswire

Fri, Nov 04, 2011

8:30 AM

Immunomedics Announces First Quarter Fiscal 2012 Results and Clinical Program Developments - Globe Newswire

Wed, Nov 02, 2011

11:17 AM

Immunomedics Announces FDA Allows Resumption of Clivatuzumab Tetraxetan Clinical Trial - Globe Newswire

Tue, Oct 11, 2011

8:15 AM

Immunomedics Awarded U.S. Patent for Cytokine-Antibody Complexes - Globe Newswire

Thu, Sep 22, 2011

4:15 PM

Immunomedics Announces Partial Clinical Hold on Clivatuzumab Tetraxetan Clinical Trial - Globe Newswire

Mon, Sep 12, 2011

8:17 AM

Immunomedics to Present at 2011 UBS Global Life Sciences Conference - Globe Newswire

Fri, Sep 02, 2011

8:30 AM

Immunomedics to Webcast Presentation at Stifel Nicolaus 2011 Healthcare Conference - Globe Newswire

Tue, Jul 19, 2011

8:30 AM

Immunomedics Awarded Additional Patent for PEGylation Method - Globe Newswire

First

1 2

Last